Physician profile
Robert I Barsky
NPI 1982641288
$1,915.17
in general payments reported to CMS, 2019-2025
26 companies · $46.53 in 2025
The $46.53 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $367 · 2020: $191 · 2021: $674 · 2022: $362 · 2023: $82.57 · 2024: $192 · 2025: $46.53.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $322.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $321.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $527.46 | 2019-2025 | Lithovue, Ams 700 |
| Astellas Pharma US INC | $278.95 | 2019-2021 | |
| Calyxo, INC. | $187.57 | 2022-2024 | Cvac Aspiration System |
| Teleflex LLC | $151.00 | 2021-2024 | Solesta |
| Antares Pharma, INC. | $135.34 | 2019-2021 | |
| Neotract INC. | $78.08 | 2019-2020 | |
| Janssen Biotech, INC. | $72.89 | 2019-2021 | |
| Medtronic, INC. | $52.34 | 2024 | Interstim |
| Baxter Healthcare | $43.15 | 2019-2020 | |
| Ambu INC. | $41.23 | 2021-2023 | |
| Urovant Sciences INC | $41.22 | 2021-2022 | |
| Endo Pharmaceuticals INC. | $39.15 | 2019-2022 | |
| Ferring Pharmaceuticals INC. | $29.86 | 2019-2020 | |
| Myovant Sciences INC. | $29.49 | 2021 | |
| Myriad Genetic Laboratories, INC. | $27.36 | 2021 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aytu Biopharma, INC. | $25.09 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $23.82 | 2020 | |
| 180 Medical, INC. | $19.74 | 2019 | |
| Laborie Medical Technologies Corp. | $18.66 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Foundation Medicine, INC. | $14.53 | 2020 | |
| Clarus Therapeutics INC. | $14.50 | 2021 | |
| Therapeuticsmd, INC. | $14.22 | 2019 | |
| Avadel Specialty Pharmaceuticals, LLC | $13.33 | 2019 | |
| Amgen INC. | $12.74 | 2019 | |
| Clinigen, INC. | $11.89 | 2019 | |
| Tolmar Pharmaceuticals, INC. | $11.56 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Barsky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.